Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shuanhuanglian oral solution (child type) for acute upper respiratory tract infection in children
ChiCTR2000033143Phase 2Completed
- Sponsor
- First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
- Start
- Sep 2009
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of shuanghuanglian in upper respiratory infection (URI) (2 arms), sponsored by First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine. Primary endpoint: Body temperature. Started Sep 2009; status: completed.
02
Drugs
shuanghuanglian
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR2000033143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033143.